Ticker
GTH

Price
-
Stock movement up
+0.01 (0.12%)
Company name
Genetron Holdings Ltd
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Diagnostics & Research
Market cap
127.29M
Ent value
377.99M
Price/Sales
0.24
Price/Book
0.23
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
34.17%
3 year return
-58.11%
5 year return
-
10 year return
-
Last updated: 2024-09-14

DIVIDENDS

GTH does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales0.24
Price to Book0.23
EV to Sales0.70

FINANCIALS

Per share

Loading...
Per share data
Current share count31.62M
EPS (TTM)-20.45
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)540.38M
Gross profit (TTM)219.96M
Operating income (TTM)-513.30M
Net income (TTM)-633.49M
EPS (TTM)-20.45
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)40.70%
Operating margin (TTM)-94.99%
Profit margin (TTM)-117.23%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash176.27M
Net receivables257.93M
Total current assets708.95M
Goodwill0.00
Intangible assets32.07M
Property, plant and equipment0.00
Total assets975.33M
Accounts payable63.05M
Short/Current long term debt0.00
Total current liabilities389.87M
Total liabilities426.97M
Shareholder's equity548.36M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)0.00
Capital expenditures (TTM)0.00
Free cash flow (TTM)0.00
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-115.53%
Return on Assets-64.95%
Return on Invested Capital-115.53%
Cash Return on Invested Capital-

STOCK INFORMATION

Downside potential

Loading...
Downside potential data
GTHS&P500
Current price drop from All-time high-95.62%-0.02%
Highest price drop-97.51%-56.47%
Date of highest drop29 Sep 20229 Mar 2009
Avg drop from high-70.21%-11.22%
Avg time to new high63 days12 days
Max time to new high786 days1805 days
COMPANY DETAILS
GTH (Genetron Holdings Ltd) company logo
Marketcap
127.29M
Marketcap category
Small-cap
Description
Genetron Holdings Limited, a precision oncology platform company, focuses on cancer management by utilizing technologies in molecular biology and data science in the People's Republic of China. It offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. The company also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. Genetron Holdings Limited was founded in 2013 and is headquartered in Beijing, the People's Republic of China.
Employees
993
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner